Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series-Reference-Cited by-同舟云学术

Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series

Published:2023-09 Issue: Volume: Page:
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Podestà Manuel Alfredo,Trillini Matias,Portalupi Valentina,Gennarini Alessia,Tomatis Federica,Villa Alessandro,Perna Annalisa,Rubis Nadia,Remuzzi Giuseppe,Ruggenenti Piero

Publisher

Elsevier BV

Subject

Nephrology

Reference40 articles.

1. Treatment of membranous nephropathy: time for a paradigm shift;Ruggenenti;Nat Rev Nephrol,2017

2. Prognosis of untreated patients with idiopathic membranous nephropathy;Schieppati;N Engl J Med,1993

3. Rituximab for idiopathic membranous nephropathy;Remuzzi;Lancet,2002

4. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy;Beck;N Engl J Med,2009

5. New “antigens” in membranous nephropathy;Sethi;J Am Soc Nephrol,2021

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel approaches to primary membranous nephropathy: Beyond the KDIGO guidelines;European Journal of Pharmacology;2024-11

2. B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges;International Immunopharmacology;2024-10

3. Obinutuzumab as Initial or Second-Line Therapy in Patients With Primary Membranous Nephropathy;Kidney International Reports;2024-08

4. Membranous nephropathy: pathogenesis and treatments;MedComm;2024-06-29

5. Ten tips on immunosuppression in primary membranous nephropathy;Clinical Kidney Journal;2024-04-29